Description |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Martin Dow |
Ondansetron 8mg/4ml |
Product Type |
Product Size |
Tablets |
28'S |
Product Company |
Himmel Pharma |
Bicalutamide 50mg |
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Martin Dow |
Anastrozole 1mg |
Product Type |
Product Size |
injection |
1'S |
Product Company |
Pharmedic |
Dacarbazine 200mg |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Roche Pharma |
Bevacizumab 100mg/4ml |
Product Type |
Product Size |
Tablet |
60'S |
Product Company |
Pharma Solution |
Erlotinib 150mg |
Content | Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting. | Bicalutamide belongs to the group of medicines called antiandrogens. It works by blocking the effects of testosterone (a male hormone), which helps stop the growth and spread of cancer cells.
| Anastrozole is a type of hormone treatment. It works by lowering the levels of oestrogen hormones in your body. It is mainly prescribed for women who have been through the menopause and have a type of cancer called hormone-dependent breast cancer. | Dacarbazine, also known as imidazole carboxamide, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma. For Hodgkin's it is often used together with vinblastine, bleomycin, and doxorubicin. | "
Bevacizumab, sold under the brand name Avastin among others, is a medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow injection into a vein and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma. | Erlotinib is an EGFR tyrosine kinase inhibitor used to treat certain small cell lung cancers or advanced metastatic pancreatic cancers. |
Reviews
There are no reviews yet.